摘要
目的:观察步长稳心颗粒治疗快速心律失常的疗效及不良反应。方法:92例快速心律失常患者随机分为2组:治疗组46例,口服步长稳心颗粒每次1包(9g),每8h 1次,共4周。对照组46例,口服心律平每次150mg,每8h 1次,共4周。用药前后做心电图及24h Holter监测评价疗效,同时监测药物不良反应。结果:步长稳心颗粒组总有效率78.3％,心律平组总有效率73.9％(P>0.05)。步长稳心颗粒组还显著改善病人的血液流变学指标。结论:步长稳心颗粒是一种安全、有效的治疗快速心律失常的药物。
Objective:To observe the effect and adverse reaction of Buchang wen xin ke li in the treatment of the patients with rapid arrhythmia. Methods: Ninety-two patients with rapid arrhythmia were randomly divided into two groups: The treatment group ( n = 46) ,were given Buchang wen xin ke li a pack (9g) orally once eight hours for 4 weeks.The control group ( n = 46), were given Propafenone 150mg orally once eight hours for 4 weeks. The changes of ECG and 24 hours Holler were observed before and after the treatment,at the same time the adverse reation were examined.Results:The total effective rate amounted to 78.3% in the patients treated with Buchang wen xin ke li, and 73.9% in those patients treated with Propafenone ( P > 0.05) , The hemorrheology marker were improved significantly in the patients treated with Buchang wen xin ke li. Conclusion: Buchang wen xin ke li is a safe and effective drug for the treatment of rapid arrhythmia.
出处
《医学理论与实践》
2003年第9期1004-1005,共2页
The Journal of Medical Theory and Practice
